semaglutide through hers Inside the Legal Battle Between Novo Nordisk and Hims & HERS Weight Loss Review |

doi: 10.3389/fendo.2018.00672 16

How do we reconcile this

A meta-analysis of retrospective cohort studies showed a consistent association between GLP-1 receptor agonist use and reduced CRC risk, though limitations, including limited granularity for individual agents and concerns about publication bias, have been noted

The new small-molecule GLP-1 pills should cost less to make and distribute than todays injectables, which require refrigeration and a more complex manufacturing process

The patients who achieve 20-25% body weight reduction with tirzepatide are not simply injecting once a week and eating whatever they want